Post-Infection Immunodeficiency Virus Control by Neutralizing Antibodies

PLoS ONE

Volumn 2, Issue 6, 2007, Pages

  Yamamoto, Hiroyuki ^a,b   Kawada, Miki ^a,b   Takeda, Akiko ^a   Igarashi, Hiroko ^b   Matano, Tetsuro ^a,b,c,d  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^d NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY;

ANIMAL; ARTICLE; BLOOD; DENDRITIC CELL; IMMUNOLOGY; MACACA; PASSIVE IMMUNIZATION; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE; VIRUS LOAD;

ANIMALS; ANTIBODIES, NEUTRALIZING; DENDRITIC CELLS; IMMUNIZATION, PASSIVE; MACACA MULATTA; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; T-LYMPHOCYTES; VIRAL LOAD;

EID: 40349092000     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0000540     Document Type: Article

References (39)

1. Koup RA, Safrit JT, Cao Y, Andrews CA, McLeod G, et al.(1994) Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol 68: 4650-4655.
2. Borrow P, Lewicki H, Hahn BH, Shaw GM, Oldstone MB, (1994) Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol 68: 6103-6110.
3. Matano T, Shibata R, Siemon C, Connors M, Lane HC, et al.(1998) Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques. J Virol 72: 164-169.
4. Schmitz JE, Kuroda MJ, Santra S, Sasseville VG, Simon MA, et al.(1999) Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 283: 857-860.
5. Jin X, Bauer DE, Tuttleton SE, Lewin S, Gettie A, et al.(1999) Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques. J Exp Med 189: 991-998.
6. Matano T, Kobayashi M, Igarashi H, Takeda A, Nakamura H, et al.(2004) Cytotoxic T lymphocyte-based control of simian immunodeficiency virus replication in a preclinical AIDS vaccine trial. J Exp Med 199: 1709-1718.
7. Goulder PJ, Watkins DI, (2004) HIV and SIV CTL escape: implications for vaccine design. Nat Rev Immunol 4: 630-640.
8. Burton DR, Desrosiers RC, Doms RW, Koff WC, Kwong PD, et al.(2004) HIV vaccine design and the neutralizing antibody problem. Nat Immunol 5: 233-236.
9. Kwong PD, Doyle ML, Casper DJ, Cicala C, Leavitt SA, et al.(2002) HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites. Nature 420: 678-682.
10. Wei X, Decker JM, Wang S, Hui H, Kappes JC, Wu X, et al.(2003) Antibody neutralization and escape by HIV-1. Nature 422: 307-312.
11. Hangartner L, Zinkernagel RM, Hengartner H, (2006) Antiviral antibody responses: the two extremes of a wide spectrum. Nat Rev Immunol 6: 231-243.
12. Richman DD, Wrin T, Little SJ, Petropoulos CJ, (2003) Rapid evolution of the neutralizing antibody response to HIV type 1 infection. Proc Natl Acad Sci U S A 100: 4144-4149.
13. Trkola A, Kuster H, Rusert P, Joos B, Fischer M, et al.(2005) Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies. Nat Med 11: 615-622.
14. Haigwood NL, Watson A, Sutton WF, McClure J, Lewis A, et al.(1996) Passive immune globulin therapy in the SIV/macaque model: early intervention can alter disease profile. Immunol Lett 51: 107-114.
15. Poignard P, Sabbe R, Picchio GR, Wang M, Gulizia RJ, et al.(1999) Neutralizing antibodies have limited effects on the control of established HIV-1 infection in vivo. Immunity 10: 431-438.
16. Nishimura Y, Igarashi T, Haigwood NL, Sadjadpour R, Donau OK, et al.(2003) Transfer of neutralizing IgG to macaques 6 h but not 24 h after SHIV infection confers sterilizing protection: implications for HIV-1 vaccine development. Proc Natl Acad Sci U S A 100: 15131-15136.
17. Mascola JR, Lewis MG, Stiegler G, Harris D, VanCott TC, et al.(1999) Protection of macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies. J Virol 73: 4009-4018.
18. Shibata R, Igarashi T, Haigwood N, Buckler-White A, Ogert R, et al.(1999) Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys. Nat Med 5: 204-210.
19. Mascola JR, Stiegler G, VanCott TC, Katinger H, Carpenter CB, et al.(2000) Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Nat Med 6: 207-210.
20. Parren PW, Marx PA, Hessell AJ, Luckay A, Harouse J, et al.(2001) Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro. J Virol 75: 8340-8347.
21. Veazey RS, Shattock RJ, Pope M, Lirijan JC, Jones J, et al.(2003) Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120. Nat Med 9: 343-346.
22. Nishimura Y, Igarashi T, Donau OK, Buckler-White A, Buckler C, et al.(2004) Highly pathogenic SHIVs and SIVs target different CD4+ T cell subsets in rhesus monkeys, explaining their divergent clinical courses. Proc Natl Aca Sci. U S A 101: 12324-12329.
23. Mattapallil JJ, Douek DC, Hill B, Nishimura Y, Martin M, et al.(2005) Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 434: 1093-1097.
24. Li Q, Duan L, Estes JD, Ma ZM, Routke T, et al.(2005) Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells. Nature 434: 1148-1152.
25. Picker LJ, Watkins DI, (2005) HIV pathogenesis: the first cut is the deepest. Nat Immunol 6: 430-432.
26. Arguello JR, Little AM, Bohan E, Goldman JM, Marsh SG, et al.(1998) High resolution HLA class I typing by reference strand-mediated conformation analysis (RSCA). Tissue Antigens 52: 57-66.
27. Sallusto F, Lanzavecchia A, (1994) Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 179: 1109-1118.
28. Pitcher CJ, Hagen SI, Walker JM, Lum R, Mitchell BL, et al.(2002) Development and homeostasis of T cell memory in rhesus macaques. J Immunol 168: 29-43.
29. Letvin NL, Mascola JR, Sun Y, Gorgone DA, Buzby AP, et al.(2006) Preserved CD4+ central memory T cells and survival in vaccinated SIV-challenged monkeys. Science 312: 1530-1533.
30. Kawada M, Igarashi H, Takeda A, Tsukamoto T, Yamamoto H, et al.(2006) Involvement of multiple epitope-specific cytotoxic T-lymphocyte responses in vaccine-based control of simian immunodeficiency virus replication in rhesus macaques. J Virol 80: 1949-1958.
31. Chakrabarti L, Isola P, Cumont MC, Claessens-Maire MA, Hurtrel M, et al.(1994) Early stages of simian immunodeficiency virus infection in lymph nodes. Evidence for high viral load and successive populations of target cells. Am J Pathol 144: 1226-1237.
32. Eitner F, Cui Y, Grouard-Vogel G, Hudkins KL, Schmidt A, et al.(2000) Rapid shift from virally infected cells to germinal center-retained virus after HIV-2 infection of macaques. Am J Pathol 156: 1197-1207.
33. Huber M, Fischer M, Misselwitz B, Manrique A, Kuster H, et al.(2006) Complement lysis activity in autologous plasma is associated with lower viral loads during the acute phase of HIV-1 infection. PLoS Medicine 3: e441.
34. Regnault A, Lankar D, Lacabanne V, Rodriguez A, Thery C, et al.(1999) Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. J Exp Med 189: 371-380.
35. Schuurhuis DH, Ioan-Facsinav A, Nagelkerken B, van Schip JJ, Sedlik C, et al.(2002) Antigen-antibody immune complexes empower dendritic cells to efficiently prime specific CD8+ CTL responses in vivo. J Immunol 168: 2240-2246.
36. Thomas PG, Brown SA, Yue W, So J, Webby RJ, et al.(2006) An unexpected antibody response to an engineered influenza virus modifies CD8+ T cell responses. Proc Natl Acad Sci U S A 103: 2764-2769.
37. Frankel SS, Steinman RM, Michael NL, Kim SR, Bhardwaj N, et al.(1998) Neutralizing monoclonal antibodies block human immunodeficiency virus type 1 infection of dendritic cells and transmission to T cells. J Virol 72: 9788-9794.
38. Lore K, Smed-Sorensen A, Vasudevan J, Mascola JR, Koup RA, (2005) Myeloid and plasmacytoid dendritic cells transfer HIV-1 preferentially to antigen-specific CD4+ T cells. J Exp Med 201: 2023-2033.
39. Castellino F, Germain RN, (2006) Cooperation between CD4+ and CD8+ T cells: When, Where, and How. Annu Rev Immunol 24: 519-540.